Written question asked by Ben Obese-Jecty (Conservative) on Thursday, 4 September 2025, in the House of Commons. It was due for an answer on Monday, 8 September 2025. It was answered by Kanishka Narayan (Labour) on Friday, 12 September 2025 on behalf of the Department for Science, Innovation and Technology.
Animal Experiments
- Question
-
To ask the Secretary of State for Science, Innovation and Technology, with reference to the UK’s Modern Industrial Strategy, CP 1337, published on 23 June 2025, what proportion of funding for preclinical infrastructure linked to translational research networks will be allocated to (a) developing non-animal methods of testing and (b) phasing out animal testing.
- Answer
-
The Government is committed to supporting non-animal alternatives and will publish a strategy to support their development, validation and adoption. The majority of the £30 million for preclinical infrastructure linked to translational research networks announced in the Industrial Strategy is expected to support alternative methods, however exact allocations are yet to be completed and will be announced in due course.
Secondary information
- Type
- Written question
- Reference
- 75340
- Session
- 2024-26
- Related items
-
The UK’s Modern Industrial Strategy
Monday, 23 June 2025
Command papers
House of Commons
House of Lords
- Subjects
- Animal experiments Finance Infrastructure Medicine Research
- Contains statistics
- Yes
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2025-09-23 16:39:08 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-25/75340
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-25/75340
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-25/75340